Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 7/20 | 0.36 |
| ▸ | OGA | O60502 | 1/20 | 0.35 |
| ▸ | PYGB | P11216 | 1/20 | 0.31 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1870755 | 1.00 | LGALS8 (0.36) | LGALS8OGAPYGBSLC2A1 | |
| SCHEMBL1979122 | 0.85 | LGALS8 (0.33) | LGALS8OGAPYGB | |
| SCHEMBL11168480 | 0.83 | LGALS8 (0.39) | LGALS8OGAPYGB | |
| SCHEMBL5183891 | 0.77 | — | — | |
| SCHEMBL393237 | 0.77 | — | — | |
| SCHEMBL3623222 | 0.77 | — | — | |
| SCHEMBL532553 | 0.77 | — | — | |
| SCHEMBL1607814 | 0.77 | — | — | |
| SCHEMBL37974 | 0.77 | — | — | |
| SCHEMBL532554 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104780927-A | Transglutaminase activator | KAO CORP | 2015-07-15 | — | — | CN | claimed |
| CN-103313696-A | Skin whitening agent | KAO CORP | 2013-09-18 | — | — | CN | claimed |
| CN-103313696-B | whitening agent | KAO CORP. (JP) | 2016-05-18 | — | — | CN | disclosed |
| CN-103313696-A | Skin whitening agent | KAO CORP | 2013-09-18 | — | — | CN | disclosed |
| EP-0641327-B1 | NOVEL ALPHA-MANNOSIDASE INHIBITORS | MERRELL PHARMA INC (US) | 1999-01-20 | — | — | EP | disclosed |
| EP-0451834-B1 | Alpha-mannosidase and fucosidase inhibitors | MERRELL PHARMA INC (US) | 1996-07-24 | — | — | EP | disclosed |
| US-5438069-A | Glucohydrolase inhibitors useful as antidiabetic agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-08-01 | — | — | US | disclosed |
| EP-0641327-A1 | NOVEL ALPHA-MANNOSIDASE INHIBITORS | MERRELL PHARMACEUTICALS INC. (US) | 1995-03-08 | — | — | EP | disclosed |
| US-5382709-A | IMMUNOSTIMULANTS, VIRICIDES AND ANTIMETASTATIC AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-01-17 | — | — | US | disclosed |
| EP-0297534-B1 | Castanospermine esters and glycosides | MERRELL DOW PHARMA (US) | 1994-12-28 | — | — | EP | disclosed |
| US-5262425-A | Immunostimulants, chemoprotective and radioprotective agents, antimetastatic agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-11-16 | — | — | US | disclosed |
| US-5240707-A | 2,3,4-trihydroxy-5-(hydroxymethyl)cyclopentylamines used as immunostimulants, viricides and antimetastasis agents | MERRELL DOW PHARMACEUTICALS INC. | 1993-08-31 | — | — | US | disclosed |
| WO-1993005781-A1 | NOVEL ALPHA-MANNOSIDASE INHIBITORS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-04-01 | — | — | WO | disclosed |
| WO-1992011867-A1 | NOVEL GLUCOHYDROLASE INHIBITORS USEFUL AS ANTIDIABETIC AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-07-23 | — | — | WO | disclosed |
| EP-0451834-A2 | Alpha-mannosidase and fucosidase inhibitors | MERRELL PHARMACEUTICALS INC. (US) | 1991-10-16 | — | — | EP | disclosed |
| US-5017563-A | Antidiabetic | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-05-21 | — | — | US | disclosed |
| EP-0297534-A2 | Castanospermine esters and glycosides | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-01-04 | — | — | EP | disclosed |